vs

Side-by-side financial comparison of Immunocore Holdings plc (IMCR) and COMSCORE, INC. (SCOR). Click either name above to swap in a different company.

Immunocore Holdings plc is the larger business by last-quarter revenue ($104.5M vs $93.5M, roughly 1.1× COMSCORE, INC.). On growth, Immunocore Holdings plc posted the faster year-over-year revenue change (24.3% vs -1.5%). COMSCORE, INC. produced more free cash flow last quarter ($2.9M vs $-35.5M). Over the past eight quarters, Immunocore Holdings plc's revenue compounded faster (21.7% CAGR vs 3.8%).

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

Comscore, Inc. is an American-based global media measurement and analytics company providing marketing data and analytics to enterprises, advertising agencies, brand marketers, and publishers.

IMCR vs SCOR — Head-to-Head

Bigger by revenue
IMCR
IMCR
1.1× larger
IMCR
$104.5M
$93.5M
SCOR
Growing faster (revenue YoY)
IMCR
IMCR
+25.9% gap
IMCR
24.3%
-1.5%
SCOR
More free cash flow
SCOR
SCOR
$38.5M more FCF
SCOR
$2.9M
$-35.5M
IMCR
Faster 2-yr revenue CAGR
IMCR
IMCR
Annualised
IMCR
21.7%
3.8%
SCOR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IMCR
IMCR
SCOR
SCOR
Revenue
$104.5M
$93.5M
Net Profit
$3.0M
Gross Margin
97.4%
41.0%
Operating Margin
-18.8%
7.0%
Net Margin
3.2%
Revenue YoY
24.3%
-1.5%
Net Profit YoY
-3.7%
EPS (diluted)
$-0.61
$9.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMCR
IMCR
SCOR
SCOR
Q4 25
$104.5M
$93.5M
Q3 25
$103.7M
$88.9M
Q2 25
$98.0M
$89.4M
Q1 25
$93.9M
$85.7M
Q4 24
$84.1M
$94.9M
Q3 24
$80.2M
$88.5M
Q2 24
$75.4M
$85.8M
Q1 24
$70.5M
$86.8M
Net Profit
IMCR
IMCR
SCOR
SCOR
Q4 25
$3.0M
Q3 25
$-177.0K
$453.0K
Q2 25
$-10.3M
$-9.5M
Q1 25
$5.0M
$-4.0M
Q4 24
$3.1M
Q3 24
$8.7M
$-60.6M
Q2 24
$-11.6M
$-1.7M
Q1 24
$-24.4M
$-1.1M
Gross Margin
IMCR
IMCR
SCOR
SCOR
Q4 25
97.4%
41.0%
Q3 25
99.5%
40.6%
Q2 25
98.9%
40.6%
Q1 25
99.1%
39.6%
Q4 24
99.6%
42.4%
Q3 24
99.4%
41.2%
Q2 24
97.7%
39.5%
Q1 24
99.7%
42.3%
Operating Margin
IMCR
IMCR
SCOR
SCOR
Q4 25
-18.8%
7.0%
Q3 25
-6.9%
1.9%
Q2 25
-15.2%
-1.9%
Q1 25
-3.9%
-2.4%
Q4 24
-23.1%
4.1%
Q3 24
-10.6%
-67.4%
Q2 24
-21.2%
-2.2%
Q1 24
-37.6%
-2.2%
Net Margin
IMCR
IMCR
SCOR
SCOR
Q4 25
3.2%
Q3 25
-0.2%
0.5%
Q2 25
-10.5%
-10.6%
Q1 25
5.4%
-4.7%
Q4 24
3.3%
Q3 24
10.9%
-68.5%
Q2 24
-15.4%
-2.0%
Q1 24
-34.7%
-1.2%
EPS (diluted)
IMCR
IMCR
SCOR
SCOR
Q4 25
$-0.61
$9.50
Q3 25
$0.00
$-0.86
Q2 25
$-0.20
$-2.73
Q1 25
$0.10
$-1.66
Q4 24
$-0.47
$-0.47
Q3 24
$0.17
$-12.79
Q2 24
$-0.23
$-1.19
Q1 24
$-0.49
$-1.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMCR
IMCR
SCOR
SCOR
Cash + ST InvestmentsLiquidity on hand
$864.2M
$23.6M
Total DebtLower is stronger
$41.5M
Stockholders' EquityBook value
$381.0M
$111.4M
Total Assets
$1.1B
$407.7M
Debt / EquityLower = less leverage
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMCR
IMCR
SCOR
SCOR
Q4 25
$864.2M
$23.6M
Q3 25
$892.4M
$26.7M
Q2 25
$882.8M
$26.0M
Q1 25
$837.0M
$31.0M
Q4 24
$820.4M
$29.9M
Q3 24
$901.3M
$20.0M
Q2 24
$859.6M
$14.7M
Q1 24
$832.8M
$18.7M
Total Debt
IMCR
IMCR
SCOR
SCOR
Q4 25
$41.5M
Q3 25
$41.4M
Q2 25
$41.3M
Q1 25
$41.3M
Q4 24
$41.2M
Q3 24
$438.7M
Q2 24
$452.5M
Q1 24
$452.5M
Stockholders' Equity
IMCR
IMCR
SCOR
SCOR
Q4 25
$381.0M
$111.4M
Q3 25
$396.6M
$-26.3M
Q2 25
$388.5M
$-21.7M
Q1 25
$378.5M
$-13.5M
Q4 24
$360.7M
$-8.3M
Q3 24
$377.8M
$-2.7M
Q2 24
$359.1M
$45.8M
Q1 24
$359.5M
$51.4M
Total Assets
IMCR
IMCR
SCOR
SCOR
Q4 25
$1.1B
$407.7M
Q3 25
$1.1B
$406.9M
Q2 25
$1.1B
$415.9M
Q1 25
$1.0B
$421.5M
Q4 24
$1.0B
$430.2M
Q3 24
$1.1B
$412.5M
Q2 24
$1.0B
$474.1M
Q1 24
$994.0M
$477.7M
Debt / Equity
IMCR
IMCR
SCOR
SCOR
Q4 25
0.37×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
1.16×
Q2 24
1.26×
Q1 24
1.26×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMCR
IMCR
SCOR
SCOR
Operating Cash FlowLast quarter
$-32.7M
$3.2M
Free Cash FlowOCF − Capex
$-35.5M
$2.9M
FCF MarginFCF / Revenue
-34.0%
3.1%
Capex IntensityCapex / Revenue
2.8%
0.3%
Cash ConversionOCF / Net Profit
1.07×
TTM Free Cash FlowTrailing 4 quarters
$-15.1M
$21.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMCR
IMCR
SCOR
SCOR
Q4 25
$-32.7M
$3.2M
Q3 25
$-4.5M
$9.5M
Q2 25
$26.0M
$932.0K
Q1 25
$435.0K
$9.1M
Q4 24
$-14.0M
$-10.0M
Q3 24
$21.1M
$12.5M
Q2 24
$23.5M
$8.7M
Q1 24
$-4.6M
$6.9M
Free Cash Flow
IMCR
IMCR
SCOR
SCOR
Q4 25
$-35.5M
$2.9M
Q3 25
$-5.2M
$9.4M
Q2 25
$25.6M
$787.0K
Q1 25
$137.0K
$8.7M
Q4 24
$-17.5M
$-10.3M
Q3 24
$20.3M
$12.4M
Q2 24
$23.1M
$8.5M
Q1 24
$-5.0M
$6.6M
FCF Margin
IMCR
IMCR
SCOR
SCOR
Q4 25
-34.0%
3.1%
Q3 25
-5.0%
10.5%
Q2 25
26.1%
0.9%
Q1 25
0.1%
10.1%
Q4 24
-20.9%
-10.8%
Q3 24
25.3%
14.0%
Q2 24
30.7%
10.0%
Q1 24
-7.1%
7.6%
Capex Intensity
IMCR
IMCR
SCOR
SCOR
Q4 25
2.8%
0.3%
Q3 25
0.7%
0.1%
Q2 25
0.4%
0.2%
Q1 25
0.3%
0.4%
Q4 24
4.3%
0.2%
Q3 24
1.0%
0.1%
Q2 24
0.4%
0.2%
Q1 24
0.6%
0.3%
Cash Conversion
IMCR
IMCR
SCOR
SCOR
Q4 25
1.07×
Q3 25
20.96×
Q2 25
Q1 25
0.09×
Q4 24
-3.19×
Q3 24
2.42×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IMCR
IMCR

Segment breakdown not available.

SCOR
SCOR

Transferred Over Time$77.1M83%
Research Insight Solutions$14.6M16%
Related Party$2.5M3%

Related Comparisons